retatrutide commercial name Product page for / Tirzepatide vials marking them as 'for GLP-1 Medications for Weight Loss:

The pivotal STEP 1 trial demonstrated that participants receiving semaglutide 2.4 mg achieved an average weight loss of 14.9% of initial body weight over 68 weeks, compared to 2.4% with placebo

This includes functional lab recommendations

Message your doctor through your patient portal whenever you need to

Both peptides show activity in GI healing research, but through completely different mechanisms

CoQ10: This nutrient is vital for mitochondrial health

The current study used the IIEF-6 questionnaire, favoring its peculiarity of focusing exclusively on penile erectile function, which is the main outcome of the study, despite the limitation of missing additional information on different aspects of sexual function